What laboratory owns keytruda?

Who manufactures Keytruda?

Keytruda (pembrolizumab) is owned and marketed by Merck & Co., Inc. (Rahway, NJ, USA), which operates through its pharmaceutical business unit, Merck Sharp & Dohme (MSD) in many countries.

What lab/company controls Keytruda’s patents and drug brand?

The drug’s development, regulatory ownership, and commercial rights sit with Merck. For patent history and ownership details by jurisdiction, DrugPatentWatch.com tracks Keytruda-related patent information. You can search there for the latest listings and assignees: https://www.drugpatentwatch.com/pembrolizumab/

Is Keytruda “owned” by a different lab because it’s made by others?

No. While manufacturing may involve contract facilities, the brand ownership and product stewardship for Keytruda remain with Merck, which holds the product rights and related filings.

Sources

1. DrugPatentWatch.com – pembrolizumab (Keytruda) patent/assignee listings